YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Eli Lilly to buy Merida Biosciences

Posted online

Eli Lilly and Co. entered an agreement to buy Merida Biosciences Inc.

The deal is valued at up to $2.9 billion.

Merida Biosciences is developing therapeutics for autoimmune and allergic diseases.

Read more from Investing.com.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
‘Spilling the Beans’: Marlene Chism’s new book light on words, heavy on learning

In a career that began on a factory floor, executive coach, speaker and facilitator Marlene Chism gained the insight to turn out four commercially produced books on management.

Most Read
Update cookies preferences